ASK REDCHAT ANYTHING ABOUT ENDRA LIFE SCIENCES INC.
ENDRA Life Sciences Inc. (NASDAQ: NDRA)
Listen to this Section
$3.95
-2.3200
(
-37.00% )
422.6K
Sign up for The Small Stocks Big Money Newsletter and receive free small-cap news and insights.
Market Data
| Open |
$3.95 |
| Previous Close |
$6.27 |
| Volume |
422.6K |
| Market Cap |
$11.59M |
| Day Range |
$3.63 - $6.67 |
| 52 Week Range |
$2.96 - $11.96 |
| Shares Outstanding |
1.85M |
| Change % |
-37.00% |
| Net Change |
▼ -2.3200 |
| Insider Ownership |
0.00% |
| Exchange |
NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| IPO Year | 2017 |
| Country | United States |
Insider Ownership Transactions
Total Amount Purchased:
1,315.00
| Date |
Type |
Amount Purchased |
Purchaser |
| 2024-08-29 |
Buy |
3715.00 |
UBS Group AG |
| 2024-02-23 |
Sale |
-600.00 |
Basenese Lou |
| 2024-02-23 |
Sale |
-600.00 |
Harsh Michael |
| 2024-02-23 |
Sale |
-600.00 |
DIGIANDOMENICO ANTHONY |
| 2024-02-23 |
Sale |
-600.00 |
Tokman Alexander Y |
SEC Filings
| Form Type |
Description |
Pages |
Date |
| 8-k |
8K-related |
14 |
May 28, 2026 |
| s-8 |
Registration statements |
15 |
May 15, 2026 |
| 10-q |
Quarterly Reports |
65 |
May 15, 2026 |
| 8-k |
8K-related |
11 |
Apr 21, 2026 |
| 8-k |
8K-related |
12 |
Mar 31, 2026 |
| 10-k |
Annual reports |
82 |
Mar 31, 2026 |
| 8-k |
8K-related |
12 |
Mar 25, 2026 |
| 4 |
Insider transactions |
1 |
Mar 04, 2026 |
| 4 |
Insider transactions |
1 |
Mar 04, 2026 |
| 4 |
Insider transactions |
1 |
Jan 23, 2026 |